MedTrace Logo

Statin for Immunomudulation in Sepsis

NCT00452608 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2009-06-26

No results posted yet for this study

Summary

The purpose of this study is to determine whether atorvastatin can improve the inflammatory answer in the septic patients

Conditions

Interventions

DRUG

amido pill

one pill of amido/d by mouth for 10 days

DRUG

atorvastatina

atorvastatina 80 mg/day by mouth for 10 days

Sponsors & Collaborators

  • Hospital de Clinicas de Porto Alegre

    lead OTHER

Principal Investigators

  • Nadine Clausell · Federal University of Rio Grande do Sul - Brazil

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00452608 on ClinicalTrials.gov